Diabetic nephropathy is a common complication of diabetes mellitus and one of the major etiologies of end-stage renal disease. Specific therapeutic interventions are necessary to treat such complications. The present study was designed to investigate the metabolomic changes induced by thymoquinone for the treatment of diabetic nephropathy, using a rodent model. Rats were divided into three different groups (n = 6 each): control, diabetic, and thymoquinonetreated diabetic groups. Metabolites in serum samples were analyzed via gas chromatography-mass spectrometry. Multiple changes were observed, including those related to the metabolism of amino acids and fatty acids. The correlation analysis suggested that treatment with thymoquinone led to the reversal of diabetic nephropathy that was associated with modulations in the metabolism and proteolysis of amino acids, fatty acids, glycerol phospholipids, and organic acids. In addition, we explored the mechanisms linking the metabolic profiling of diabetic nephropathy, with a particular emphasis on the potential roles of increased reactive oxygen species production and mitochondrial dysfunctions. Our findings demonstrated that metabolomic profiling provided significant insights into the basic mechanisms of diabetic nephropathy and the therapeutic effects of thymoquinone.
Diabetes mellitus (DM) is a metabolic disorder prevalent worldwide and results in chronic glucotoxicity. The notion of β cell glucotoxicity implies that hyperglycemia can exert toxic consequences on β cell function after the induction of diabetes by genetic or environmental factors or chemicals [1] . Streptozotocin (STZ) is commonly used for the induction of diabetes in rats [2, 3] . Diabetic nephropathy (DN) is a common complication of DM and one of the major etiologies of end-stage renal disease (ESRD) [4] . DN is characterized by several renal anomalies, including basement membrane thickening, glomerulosclerosis, and tubule-interstitial fibrosis [5, 6] . STZ-induced pancreatic damage is frequently used to generate animal models of type 1 diabetes, which develop renal injury similar to that observed in human DN. This model can be used to examine the development and progression of DN [7] . Several reports have shown that metabolomics can be used for the diagnosis of disease, identification of biomarkers, and assessment of drug efficacy and toxicity [8] [9] [10] [11] [12] . Metabolomic profiling can screen for metabolic changes within a biological system and identify the mechanisms and pathways involved with a disease. Thymoquinone (TQ) (Figure 1 ; 2-isopropyl-5-methylbenzo-1,4quinone; molar mass, 164.20 g/mol) is a phytochemical found in Nigella sativa. Mahfouz and El-Dakhakhny [13] reported the identification of "a polymer of the active principle" and termed it nigellone. This component was isolated from the essential oil of the nigella seeds. In 1963, El-Dakhakhny [14] isolated a crystalline substance from the essential oil, which he identified as TQ. It has been demonstrated that TQ is the major constituent of Nigella sativa and shows antimicrobial, antioxidant, antihistaminergic, antiinflammatory, antidiabetic, analgesic, antipyretic, and antineoplastic activities. The antineoplastic activity has recently received a significant amount of attention [15] . TQ has demonstrated several pharmacological properties including hepato-, reno-, and cardio-protective effects in animal models [16] [17] [18] . It has also been shown to have protective effects in experimental DN and to ameliorate cisplatin-induced nephrotoxicity in rodents [16, 19] . To explore whether TQ could mitigate the progress of DN by the regulation of specific metabolic pathways, integrated gas chromatography-mass spectrometry (GC-MS)-based metabolomic and histological evaluations were conducted. Our aim was to identify metabolic signatures associated with TQ treatment in rats with DN.
Diabetic rats displayed constant hyperglycemia, which was associated with significant weight loss compared with the control group. Treatment with TQ caused a clear reduction in the raised glucose levels of rats with DM ( Figure 2A ). Furthermore, it ameliorated the effects of DM on the body ( Figure 2B ). The initial and final body weights were not statistically different between the control and TQ-treated diabetic rats. Blood urea nitrogen (BUN), creatinine, 24-h urea protein, and uric acid were significantly elevated in diabetic rats, which was consistent with the development of DN. TQ treatment mitigated the increases in BUN, creatinine, 24-h urea protein ( Figure 3A ), and uric acid ( Figure 3B ). Lipid peroxidation (LPO) oxidative stress markers, including thiobarbituric acid reactive substance (TBARS) levels, markedly increased in the kidney tissues of diabetic rats than in those of normal rats. TQ treatment noticeably reduced the TBARS levels ( Figure 3C ), and the antioxidative effect of enzymes including The majority of these metabolites were classified as amino acids, fatty acids, polyols, and TCA pathway metabolites ( Table 1) . GC-MS analysis of the serum samples revealed increased concentrations of leucine, isovalerylalanine, glycine, and L-proline in the diabetic rats, which indicated a disturbance in branched-chain amino acid metabolism. A rise in the level of essential fatty acids (oleic, palmitic, and tetradecanoic acids) was also observed, which reflected lipotoxicity in STZ-treated rats. The levels of palmitic and stearic acid were significantly attenuated in TQ-treated diabetic rats; this led to a reduction in uric acid metabolism, which signified the suppression of DN. High glucose levels in the diabetic condition induce the polyol pathway in serum, which is not insulin sensitive, and aldose reductase (AR), the rate-limiting enzyme in the pathway, reduces glucose to sorbitol, which in turn is metabolized to fructose by sorbitol dehydrogenase. D-Glucitol, also known as D-sorbitol, and β-D-glycopyranoside serum levels were upregulated in diabetic rats and downregulated by TQ treatment. Similarly, the upregulation of D-sorbitol and β-D-glycopyranoside was observed, which reflected the increase in the AR pathway in diabetic rats.
High levels of sorbitol and fructose promote the accumulation of advanced glycation end products (AGEs) that led to the accumulation of intracellular ROS and nitrosative stress, which inflict renal injury. TQ treatment may mitigate intracellular ROS and nitrosative stress owing to its antioxidant activity. The gluconeogenic precursors (i.e., alanine, glycerol, and lactate) also significantly increased in diabetic rats, which indicated that proteolysis and lipolysis was enhanced. TQ significantly downregulated proteolysis and lipolysis in treated animals and the increased body weight supported these findings.
Histopathological examination demonstrated that healthy rats had renal parenchyma with normal glomeruli and tubules ( Figure 4A ). Animals with DN exhibited changes that were indicative of the dilation of mesangial tubule necrosis and swelling of the epithelial cells with slight loss in brush border integrity ( Figure 4B ). TQtreated diabetic rats showed an intact tubular epithelium with mild swelling and focal fibrosis ( Figure 4C ). In the present investigation, we demonstrated that TQ mitigated the progress of DN by the regulation of specific metabolic pathways. TQ likely to act on diabetic condition as it act by its antioxidant pathways. Therefore, the change in redox potential is necessary. Hence TQ does not alter the physiology of normal animals until provided with toxic doses. Several studies showed that an oral TQ dose in the range of 10-100 mg/kg body weight did not result in toxicity or death. In the present study, the oral dose of TQ was 20 mg/kg. This dose does not alter the biochemical parameters of normal rats, which was endorsed by our previous study on sepsis in a mice model, and also noted in other studies wherein researchers The results are presented as the mean ± SD of six animals per group. "*" denotes significant differences from the streptozotocin (STZ)-induced diabetic group (p < 0.05); "#" denotes significant difference from normal control.
have administered TQ to normal rats and found no significant deviation from normal parameters. Therefore, we concluded that TQ did not affect normal rats [18, 20, 21] . In our previous study on TQ interaction with glibenclamide, the biochemical markers were not significantly altered [18, 22] . Though the metabolomic profiling shows extra pancreatic effect and mild toxicity associated with hyperlipidemia and acute pancreatitis". The vehicle effects in thymoquinone administration are also necessary. The administration treatment is also stressful, and it is strongly estimated that blood sugar level and other biomarkers might be changed. In the present study 0.01 % of DMSO in saline solution has been used for administration of TQ in all groups of rats and maintained similar conditions for handling rats. Therefore, nullifying the stressful effect of vehicle on each group. The depression like behavior in rats were observed with the TQ administration and that is similar to previous report [23] .
Furthermore, TQ alleviated the development of DN, as indicated by reductions in kidney injury markers, such as BUN, creatinine, and 24-h urea protein [20] . Hyperglycemia contributes to oxidative and osmotic stress, which leads to diabetic microvascular complications including DN [24, 25] . TQ is known to have antioxidant properties [26] [27] [28] . In addition, the oxidative stress markers (i.e., MDA, GSH, SOD, and catalase) evaluated in our study indicated the antioxidative potential of TQ treatment in DM. The polyol pathway is the major source of DM-induced oxidative stress [29] . AR is the main enzyme in the polyol pathway and has been identified as a drug target for the treatment of DM [30] .
The high blood levels of amino acids in uncontrolled DM presumably arise because of disturbances in their production and/or utilization. Changes in amino acid metabolism have been observed in the pre-diabetic state in human and animal models [31] [32] [33] . For example, the increased concentration of leucine, isovalerylalanine, glycine, and L-proline in the diabetic rats indicated a disturbance in the metabolism of branched-chain amino acids [34] . In this study, TQ treatment attenuated amino acid levels in animals with DM, which is consistent with that observed in a previous report by Connor and colleagues [35] . In nonhuman primate and mouse models of type 2 DM, L-proline has been implicated in the decrease of levels of the SLC6A20 kidney transporter [36] . In addition, an increase in insulin concentration may reduce amino acid levels in DM [37, 38] . Finally, increased glucose production and gluconeogenesis from glucogenic amino acids have been reported in DM [39] .
Fatty acids, which are independent markers in the progression of DM [40] , impair insulin action through the Randle cycle, which leads to the accumulation of intracellular lipid derivatives, oxidative stress, inflammation, and mitochondrial dysfunction [41] . Cellular injury enacted by lipids (lipotoxicity) has been associated with the pathology of metabolic syndrome and DN [42] . Levels of nonessential fatty acids (i.e., oleic acid, palmitic acid, palmitoleic acid, stearic acid, stearoyl carnitine, 2-hydroxybutanoic acid, and 3hydroxybutanoic acid) were increased in patients with DM [43] [44] [45] . Metabolomic data indicated that oleic, palmitic, palmitoleic, and stearic acids increased in rats with STZ-induced DN. TQ treatment significantly reduced free fatty acids in this model. Moreover, the increase in fatty acids (oleic acid, palmitic acid, octadecanoic acid, and stearic acid) induced ceramides that can lead to the induction of cytochrome C and apoptosis in muscles [46] . Decreases in ceramide levels can reverse the self-perpetuating cycle of insulin resistance and metabolic syndrome [47] . The results of this study clearly illustrated a reduction in free fatty acid levels (e.g., oleic acid, palmitic acid, octadecanoic acid, and stearic acid) in diabetic rats treated with TQ.
Dysregulation of PPAR expression leads to metabolic diseases such as DM [48] . TQ is an inhibitor of γ-PARP, ERK, and protein tyrosine kinase Mohammad et al. 2013; [49] and hence its administration downregulated serum β-D-glycopyranoside and sorbitol levels. Interestingly, γ-PARP stimulation plays a key role in early DN and in renal inflammation [50] [51] [52] . Stimulation of PPAR leads to increased insulin sensitivity and decreases in blood pressure [53] . The metabolites of the fatty acid pathway are associated with diabetes [54] . There was a sharp increase in lipolysis and proteolysis in diabetic rats, as evidenced by the decrease in body weight and glycerol level, which is a marker for gluconeogenesis [55] . TQ was shown to inhibit lipolysis and proteolysis as well as serum glycerol levels in rats fed ethanol and a high-fat diet [56] . Fararh and colleagues [57] have reported that hepatic glucose from gluconeogenic precursors (i.e., alanine, glycerol, and lactate) was significantly lowered in Nigella sativa-treated hamsters. Our present study also showed a reduction in glycerol and lactic acid levels in TQ-treated rats. The results of the histopathological examination indicated the mitigation of STZ-induced renal injuries by TQ in diabetic rats. There was a sharp reduction in inflammation and focal fibrosis as well as in mesangial tubule necrosis. Many parameters of the "metabolomic profiling" in TQ treated-STZ-rats were strongly lower than those of normal rats, as shown in Table 1 . TQ enhances and stimulates glucose uptake and utilization by peripheral tissues suggesting an extra pancreatic effect and mild toxicity associated with hyperlipidemia and acute pancreatitis [14, [57] [58] [59] .
In conclusion, the GC-MS-based metabolomic analysis of serum samples showed important metabolic alterations in DM. TQ was able to ameliorate these changes in diabetic rats as indicated by the normalization of specific metabolite levels. Further studies are required to evaluate the exact molecular mechanisms and the clinical implications of these observations.
Experimental
Chemicals and reagents: TQ, STZ, and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (St Louis, MO, USA). HPLC-grade methanol was obtained from Panreac Chemicals (Barcelona, Spain). Potassium dihydrogen phosphate was procured from Winlab Ltd (Maidenhead, Berkshire, UK). Water was produced in the laboratory using a Milli-Q purification system (Millipore Corp., Billerica, MA, USA). All other reagents used were of analytical grade.
Animals and treatment:
Wistar rats (150-200 g) were obtained from the Central Animal House Facility at the College of Pharmacy, King Saud University (Riyadh, KSA). The animals were housed in groups of six in standard plastic cages under a 12-h light/dark cycle at 25 ± 2ºC, with free access to a standard rat pellet diet manufactured by Grain Silos & Flour Mills Organization (Riyadh, KSA) and water throughout the study. For 12 h prior to dosing, the rats were fasted. All procedures were approved by the Ethics Committee of College of Pharmacy, King Saud University. The rats were acclimatized to laboratory conditions for a week before the initiation of the experiments. DM was induced in overnight-fasted rats via intraperitoneal administration of STZ at a dose of 55 mg/kg in citric acid buffer (pH 4.5). One hour after the STZ administration, the rats were provided access to food ad libitum. The animals were kept under observation and fasting blood glucose levels were estimated at 72 h after STZ treatment. Rats with blood glucose levels >19 mm/L were considered diabetic and used for the study. Diabetic rats were randomly divided into two groups (n = 6 in each group). Group I rats served as the diabetic control and were injected with the vehicle. Group II rats received daily oral administration of TQ (20 mg/kg) for 2 weeks after the induction of DM by STZ.
Healthy rats (n = 6) were used as normal controls. Blood samples were collected and serum was separated for biochemical analysis.
Biochemical analysis:
At the end of the experiment (after 2 weeks), animals were euthanized, and the kidneys were harvested and homogenized for the estimation of lipid peroxidation, which was measured by the concentration of TBARS [60] , glutathione (GSH) [61, 62] , as well as the activities of catalase and superoxide dismutase (SOD) [63] [64]. In addition, creatinine, uric acid, and urea levels were estimated in serum samples by using a Reflotron Plus analyzer and Roche Kits (Roche Diagnostics, Indianapolis, IN, USA).
Metabolomic profiling:
The serum samples were thawed at 24 ºC prior to analysis. Acetonitrile (250 µL) of was added into 100 µL of sample in a 1.5 mL centrifuge tube to precipitate the protein. The mixture was ultrasonically extracted for 10 min, followed by centrifugation (10,000 rpm) for another 10 min. The supernatant was then transferred to a centrifuge tube and evaporated to dryness under a stream of nitrogen gas. Approximately 100 µL of methoxyamine HCl/pyridine solution (20 mg/mL) was added to the vial. Methoximation was performed at 60 °C for 1 h, and then 50 µL of N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS) was added to the vial. After the silylation was performed at 70 °C for 1 h, 150 µL of n-heptane was added. The mixture was then centrifuged for 10 min, and the supernatant was transferred into a GC micro vial for the GC-MS analysis. Chromatographic analysis was performed using a Perkin Elmer Clarus 600T series GC-MS (Waltham, MA, USA) equipped with an Elite 5MS capillary column (30 m × 0.25 µm × 25 mm). The initial temperature (40 °C) was maintained for 5 min, raised to 150 °C at a rate of 5 °C/min, and then increased to 300 °C and maintained for 5 min. All samples were injected in split mode at 200 °C and the ion source temperature was set at 230 °C. The mass spectrometer was operated in EI mode (positive ion, 70 eV) with the quadrupole maintained at 220 °C. Mass spectra were acquired in full scan mode with repetitive scanning from 40-600 m/z in 1 s.
Histopathological evaluation:
The kidneys were surgically removed and fixed with 10% neutral-buffered formalin, dehydrated in gradient of ethanol (80-100‰), cleared in xylene, and embedded in paraffin. Sections (3-µm thick) were prepared and then stained with hematoxylin and eosin. Renal architecture was observed for Bowman's capsule and the distribution and total area occupied by glomerular capillaries.
Statistical analysis:
Data are presented as the mean ± standard deviation (SD). Differences between groups were assessed by Student's t-test. A value of p < 0.05 was considered statistically significant. All statistical analyses were performed using GraphPad Prism 5 (Graphpad Software, Inc., San Diego, CA, USA).
